Literature DB >> 32112660

Int22h1/Int22h2-mediated Xq28 duplication syndrome: de novo duplications, prenatal diagnoses, and additional phenotypic features.

Rami A Ballout1,2, Cheryl Dickerson3, Myra J Wick4, Najla Al-Sweel5,6, Amanda S Openshaw6, Siddharth Srivastava7, Lindsay C Swanson7, Nuria C Bramswig8, Alma Kuechler8, Bo Hong5,6, Leah R Fleming9, Kathryn Curry9, Stephen P Robertson10, Erica F Andersen5,6, Ayman W El-Hattab11.   

Abstract

Int22h1/Int22h2-mediated Xq28 duplication syndrome is a relatively new X-linked intellectual disability syndrome, arising from duplications of the subregion flanked by intron 22 homologous regions 1 and 2 on the q arm of chromosome X. Its primary manifestations include variable cognitive deficits, distinct facial dysmorphia, and neurobehavioral abnormalities that mainly include hyperactivity, irritability, and autistic behavior. Affected males are hemizygous for the duplication, which explains their often more severe manifestations compared with heterozygous females. In this report, we describe the cases of nine individuals recently identified having the syndrome, highlighting unique and previously unreported findings of this syndrome. Specifically, we report for the first time in this syndrome, two cases with de novo duplications, three receiving prenatal diagnosis with the syndrome, and three others having atypical versions of the duplication. Among the latter, one proband has a shortened version spanning only the centromeric half of the typical duplication, while the other two cases have a nearly identical length duplication as the classical duplication, with the exception that their duplication's breakpoints are telomerically shifted by about 0.2 Mb. Finally, we shed light on two new manifestations in this syndrome, vertebral anomalies and multiple malignancies, which possibly expand the phenotypic spectrum of the syndrome.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  BRCC3; CLIC2; MECP2; RAB39B; autism; gene dosage; intellectual disability; sex chromosome

Mesh:

Year:  2020        PMID: 32112660      PMCID: PMC7292747          DOI: 10.1002/humu.24009

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.700


  28 in total

1.  Human serum lipoprotein concentrations.

Authors:  F W GLAZIER; A R TAMPLIN; B STRISOWER; O F DELALLA; J W GOFMAN; T R DAWBER; E PHILLIPS
Journal:  J Gerontol       Date:  1954-10

2.  Int22h-1/int22h-2-mediated Xq28 rearrangements: intellectual disability associated with duplications and in utero male lethality with deletions.

Authors:  Ayman W El-Hattab; Ping Fang; Weihong Jin; Jeffrey R Hughes; James B Gibson; Gayle S Patel; Dorothy K Grange; Linda P Manwaring; Ankita Patel; Pawel Stankiewicz; Sau Wai Cheung
Journal:  J Med Genet       Date:  2011-10-08       Impact factor: 6.318

3.  An X-linked channelopathy with cardiomegaly due to a CLIC2 mutation enhancing ryanodine receptor channel activity.

Authors:  Kyoko Takano; Dan Liu; Patrick Tarpey; Esther Gallant; Alex Lam; Shawn Witham; Emil Alexov; Alka Chaubey; Roger E Stevenson; Charles E Schwartz; Philip G Board; Angela F Dulhunty
Journal:  Hum Mol Genet       Date:  2012-07-19       Impact factor: 6.150

4.  VBP1 represses cancer metastasis by enhancing HIF-1α degradation induced by pVHL.

Authors:  Ji Ae Kim; Da Kyung Choi; Jung Sun Min; Inho Kang; Jin Chul Kim; Semi Kim; Jeong Keun Ahn
Journal:  FEBS J       Date:  2017-12-12       Impact factor: 5.542

Review 5.  Fragile X and X-linked intellectual disability: four decades of discovery.

Authors:  Herbert A Lubs; Roger E Stevenson; Charles E Schwartz
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

6.  The systematic functional characterisation of Xq28 genes prioritises candidate disease genes.

Authors:  Anja Kolb-Kokocinski; Alexander Mehrle; Stephanie Bechtel; Jeremy C Simpson; Petra Kioschis; Stefan Wiemann; Ruth Wellenreuther; Annemarie Poustka
Journal:  BMC Genomics       Date:  2006-02-17       Impact factor: 3.969

7.  The intellectual disability protein RAB39B selectively regulates GluA2 trafficking to determine synaptic AMPAR composition.

Authors:  Maria Lidia Mignogna; Maila Giannandrea; Antonia Gurgone; Francesca Fanelli; Francesco Raimondi; Lisa Mapelli; Silvia Bassani; Huaqiang Fang; Eelco Van Anken; Massimo Alessio; Maria Passafaro; Silvia Gatti; José A Esteban; Richard Huganir; Patrizia D'Adamo
Journal:  Nat Commun       Date:  2015-03-18       Impact factor: 14.919

8.  Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers.

Authors:  Gloria H J Chan; Pei Yi Ong; Jeffrey J H Low; Hwai Loong Kong; Samuel G W Ow; David S P Tan; Yi Wan Lim; Siew Eng Lim; Soo-Chin Lee
Journal:  Oncotarget       Date:  2018-07-17

9.  Chloride intracellular channel protein 2 in cancer and non-cancer human tissues: relationship with tight junctions.

Authors:  Yoshitomo Ueno; Saya Ozaki; Akihiro Umakoshi; Hajime Yano; Mohammed E Choudhury; Naoki Abe; Yutaro Sumida; Jun Kuwabara; Rina Uchida; Afsana Islam; Kohei Ogawa; Kei Ishimaru; Toshihiro Yorozuya; Takeharu Kunieda; Yuji Watanabe; Yasutsugu Takada; Junya Tanaka
Journal:  Tissue Barriers       Date:  2019-03-31

Review 10.  Distal Xq duplication and functional Xq disomy.

Authors:  Damien Sanlaville; Caroline Schluth-Bolard; Catherine Turleau
Journal:  Orphanet J Rare Dis       Date:  2009-02-20       Impact factor: 4.123

View more
  1 in total

1.  Clinical characterization of a novel RAB39B nonstop mutation in a family with ASD and severe ID causing RAB39B downregulation and study of a Rab39b knock down mouse model.

Authors:  Maria Lidia Mignogna; Romina Ficarella; Susanna Gelmini; Lucia Marzulli; Emanuela Ponzi; Alessandra Gabellone; Antonia Peschechera; Massino Alessio; Lucia Margari; Mattia Gentile; Patrizia D'Adamo
Journal:  Hum Mol Genet       Date:  2022-05-04       Impact factor: 5.121

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.